Filing Details

Accession Number:
0001348324-14-000078
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-12 16:47:01
Reporting Period:
2014-12-10
Filing Date:
2014-12-12
Accepted Time:
2014-12-12 16:47:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1348324 Ldr Holding Corp LDRH Surgical & Medical Instruments & Apparatus (3841) 203933262
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1387652 Robert Mcnamara 13785 Research Blvd., Suite 200
Austin TX 78750
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-10 241 $4.19 587 No 4 M Direct
Common Stock Disposition 2014-12-10 241 $32.00 346 No 4 S Direct
Common Stock Acquisiton 2014-12-11 1,750 $4.19 2,096 No 4 M Direct
Common Stock Disposition 2014-12-11 1,750 $32.00 346 No 4 S Direct
Common Stock Acquisiton 2014-12-11 3,564 $4.19 3,910 No 4 M Direct
Common Stock Disposition 2014-12-11 3,564 $32.00 346 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2014-12-10 241 $0.00 241 $4.19
Common Stock Incentive Stock Option (right to buy) Disposition 2014-12-11 1,750 $0.00 1,750 $4.19
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-12-11 3,564 $0.00 3,564 $4.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,215 2013-04-23 2022-05-21 No 4 M Direct
8,465 2013-04-23 2022-05-21 No 4 M Direct
15,152 2013-04-23 2022-05-21 No 4 M Direct
Footnotes
  1. ISO becomes exercisable in combination with NQSO granted on the same date wherein 25% of the shares granted become exercisable upon one year from the vesting commencement date of April 23, 2012, then in thirty-six equal monthly installments thereafter.